Clinical Trial Update: KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial [EARLY_Phase 1]

View source ↗

Summary

Exploratory EARLY_PHASE1 trial of KSD-101 for EBV-associated nasopharyngeal carcinoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection
• Nasopharyngeal Carcinoma

Drugs mentioned

• KSD-101

Snippet

Sponsor: Kousai Bio Co., Ltd. | Conditions: Nasopharyngeal Carcinoma (NPC), EBV | EARLY_Phase 1 | Status: NOT_YET_RECRUITING